Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The Ski proto-oncogene regulates body composition and suppresses lipogenesis

Abstract

Objective:

The Ski gene regulates skeletal muscle differentiation in vitro and and in vivo. In the c-Ski overexpression mouse model there occurs marked skeletal muscle hypertrophy with decreased adipose tissue mass. In this study, we have investigated the underlying molecular mechanisms responsible for the increased skeletal muscle and decreased adipose tissue mass in the c-Ski mouse.

Approach:

Growth and body composition analysis (tissue weights and dual energy X-ray absorptiometry) coupled with skeletal muscle and white adipose gene expression and metabolic phenotyping in c-Ski mice and wild-type (WT) littermate controls was performed.

Results:

The growth and body composition studies confirmed the early onset of accelerated body growth, with increased lean mass and decreased fat mass in the c-Ski mice. Gene expression analysis in skeletal muscle from c-Ski mice compared with WT mice showed significant differences in myogenic and lipogenic gene expressions that are consistent with the body composition phenotype. Skeletal muscle of c-Ski mice had significantly repressed Smad1, 4, 7 and myostatin gene expression and elevated myogenin, myocyte enhancer factor 2, insulin-like growth factor-1 receptor and insulin-like growth factor-2 expression. Strikingly, expression of the mRNAs encoding the master lipogenic regulators, sterol-regulatory enhancer binding protein 1c (SREBP1c), and the nuclear receptor liver X-receptor-α, and their downstream target genes, SCD-1 and FAS, were suppressed in skeletal muscle of c-Ski mice, as were the expressions of other nuclear receptors involved in adipogenesis and metabolism, such as peroxisome proliferator-activated receptor-γ, glucocorticoid receptor and retinoic acid receptor-related orphan receptor-α. Transfection analysis demonstrated Ski repressed the SREBP1c promoter. Moreover, palmitate oxidation and oxidative enzyme activity was increased in skeletal muscle of c-Ski mice. These results suggest that the Ski phenotype involves attenuated lipogenesis, decreased myostatin signalling, coupled to increased myogenesis and fatty acid oxidation.

Conclusion:

Ski regulates several genetic programs and signalling pathways that regulate skeletal muscle and adipose mass to influence body composition development, suggesting that Ski may have a role in risk for obesity and metabolic disease.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Namciu S, Lyons GE, Micales BK, Heyman HC, Colmenares C, Stavnezer E . Enhanced expression of mouse c-ski accompanies terminal skeletal muscle differentiation in vivo and in vitro. Dev Dyn 1995; 204: 291–300.

    Article  CAS  Google Scholar 

  2. Sutrave P, Kelly AM, Hughes SH . ski can cause selective growth of skeletal muscle in transgenic mice. Genes Dev 1990; 4: 1462–1472.

    Article  CAS  Google Scholar 

  3. Berk M, Desai SY, Heyman HC, Colmenares C . Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development. Genes Dev 1997; 11: 2029–2039.

    Article  CAS  Google Scholar 

  4. Li Y, Turck CM, Teumer JK, Stavnezer E . Unique sequence, ski, in Sloan–Kettering avian retroviruses with properties of a new cell-derived oncogene. J Virol 1986; 57: 1065–1072.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Colmenares C, Sutrave P, Hughes SH, Stavnezer E . Activation of the c-ski oncogene by overexpression. J Virol 1991; 65: 4929–4935.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Leferovich JM, Lana DP, Sutrave P, Hughes SH, Kelly AM . Regulation of c-ski transgene expression in developing and mature mice. J Neurosci 1995; 15: 596–603.

    Article  CAS  Google Scholar 

  7. Takeda M, Mizuide M, Oka M, Watabe T, Inoue H, Suzuki H et al. Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski. Mol Biol Cell 2004; 15: 963–972.

    Article  CAS  Google Scholar 

  8. Xu W, Angelis K, Danielpour D, Haddad MM, Bischof O, Campisi J et al. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Proc Natl Acad SciUSA 2000; 97: 5924–5929.

    Article  CAS  Google Scholar 

  9. Suzuki H, Yagi K, Kondo M, Kato M, Miyazono K, Miyazawa K . c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements. Oncogene 2004; 23: 5068–5076.

    Article  CAS  Google Scholar 

  10. Mizuide M, Hara T, Furuya T, Takeda M, Kusanagi K, Inada Y et al. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN. J Biol Chem 2003; 278: 531–536.

    Article  CAS  Google Scholar 

  11. Feng XH, Derynck R . Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 2005; 21: 659–693.

    Article  CAS  Google Scholar 

  12. McPherron AC, Lawler AM, Lee SJ . Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83–90.

    Article  CAS  Google Scholar 

  13. McPherron AC, Lee SJ . Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 2002; 109: 595–601.

    Article  CAS  Google Scholar 

  14. Berkes CA, Tapscott SJ . MyoD and the transcriptional control of myogenesis. Semin Cell Dev Biol 2005; 16: 585–595.

    Article  CAS  Google Scholar 

  15. Ichikawa K, Nagase T, Ishii S, Asano A, Mimura N . Trans-regulation of myogenin promoter/enhancer activity by c-ski during skeletal-muscle differentiation: the C-terminus of the c-Ski protein is essential for transcriptional regulatory activity in myotubes. Biochem J 1997; 328 (Part 2): 607–613.

    Article  CAS  Google Scholar 

  16. Kobayashi N, Goto K, Horiguchi K, Nagata M, Kawata M, Miyazawa K et al. c-Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases. Genes Cells 2007; 12: 375–385.

    Article  CAS  Google Scholar 

  17. Engert JC, Servaes S, Sutrave P, Hughes SH, Rosenthal N . Activation of a muscle-specific enhancer by the Ski proto-oncogene. Nucleic Acids Res 1995; 23: 2988–2994.

    Article  CAS  Google Scholar 

  18. Dahl R, Kieslinger M, Beug H, Hayman MJ . Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling. Proc Natl Acad Sci USA 1998; 95: 11187–11192.

    Article  CAS  Google Scholar 

  19. Zhao HL, Ueki N, Marcelain K, Hayman MJ . The Ski protein can inhibit ligand induced RARalpha and HDAC3 degradation in the retinoic acid signaling pathway. Biochem Biophys Res Commun 2009; 383: 119–124.

    Article  CAS  Google Scholar 

  20. Nomura T, Khan MM, Kaul SC, Dong HD, Wadhwa R, Colmenares C et al. Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev 1999; 13: 412–423.

    Article  CAS  Google Scholar 

  21. Ueki N, Zhang L, Hayman MJ . Ski can negatively regulates macrophage differentiation through its interaction with PU.1. Oncogene 2008; 27: 300–307.

    Article  CAS  Google Scholar 

  22. Ueki N, Zhang L, Hayman MJ . Ski negatively regulates erythroid differentiation through its interaction with GATA1. Mol Cell Biol 2004; 24: 10118–10125.

    Article  CAS  Google Scholar 

  23. Sutrave P, Copeland TD, Showalter SD, Hughes SH . Characterization of chicken c-ski oncogene products expressed by retrovirus vectors. Mol Cell Biol 1990; 10: 3137–3144.

    Article  CAS  Google Scholar 

  24. MacArthur DG, Seto JT, Chan S, Quinlan KG, Raftery JM, Turner N et al. An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Hum Mol Genet 2008; 17: 1076–1086.

    Article  CAS  Google Scholar 

  25. Lau P, Nixon SJ, Parton RG, Muscat GE . RORalpha regulates the expression of genes involved in lipid homeostasis in skeletal muscle cells: caveolin-3 and CPT-1 are direct targets of ROR. J Biol Chem 2004; 279: 36828–36840.

    Article  CAS  Google Scholar 

  26. Lau P, Fitzsimmons RL, Raichur S, Wang SC, Lechtken A, Muscat GE . The orphan nuclear receptor, RORalpha, regulates gene expression that controls lipid metabolism: staggerer (SG/SG) mice are resistant to diet-induced obesity. J Biol Chem 2008; 283: 18411–18421.

    Article  CAS  Google Scholar 

  27. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA . Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 2000; 279: E1039–E1044.

    Article  CAS  Google Scholar 

  28. Turner N, Bruce CR, Beale SM, Hoehn KL, So T, Rolph MS et al. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 2007; 56: 2085–2092.

    Article  CAS  Google Scholar 

  29. Muscat GE, Wagner BL, Hou J, Tangirala RK, Bischoff ED, Rohde P et al. Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors. J Biol Chem 2002; 277: 40722–40728.

    Article  CAS  Google Scholar 

  30. Colmenares C, Teumer JK, Stavnezer E . Transformation-defective v-ski induces MyoD and myogenin expression but not myotube formation. Mol Cell Biol 1991; 11: 1167–1170.

    Article  CAS  Google Scholar 

  31. Florini JR, Ewton DZ, Coolican SA . Growth hormone and the insulin-like growth factor system in myogenesis. Endocrine Rev 1996; 17: 481–517.

    CAS  Google Scholar 

  32. Jones BK, Levorse J, Tilghman SM . Deletion of a nuclease-sensitive region between the Igf2 and H19 genes leads to Igf2 misregulation and increased adiposity. Hum Mol Genet 2001; 10: 807–814.

    Article  CAS  Google Scholar 

  33. Erbay E, Park IH, Nuzzi PD, Schoenherr CJ, Chen J . IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. J Cell Biol 2003; 163: 931–936.

    Article  CAS  Google Scholar 

  34. Kamei Y, Miura S, Suganami T, Akaike F, Kanai S, Sugita S et al. Regulation of SREBP1c gene expression in skeletal muscle: role of retinoid X receptor/liver X receptor and forkhead-O1 transcription factor. Endocrinology 2008; 149: 2293–2305.

    Article  CAS  Google Scholar 

  35. Chu K, Miyazaki M, Man WC, Ntambi JM . Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation. Mol Cell Biol 2006; 26: 6786–6798.

    Article  CAS  Google Scholar 

  36. Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, Walczak R et al. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 2002; 277: 11019–11025.

    Article  CAS  Google Scholar 

  37. Lee SJ, McPherron AC . Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 2001; 98: 9306–9311.

    Article  CAS  Google Scholar 

  38. Feldman BJ, Streeper RS, Farese Jr RV, Yamamoto KR . Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci USA 2006; 103: 15675–15680.

    Article  CAS  Google Scholar 

  39. Ma K, Mallidis C, Artaza J, Taylor W, Gonzalez-Cadavid N, Bhasin S . Characterization of 5′-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Physiol Endocrinol Metab 2001; 281: E1128–E1136.

    Article  CAS  Google Scholar 

  40. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ et al. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem 1994; 269: 13779–13784.

    CAS  PubMed  Google Scholar 

  41. Mingrone G, Rosa G, Greco AV, Manco M, Vega N, Nanni G et al. Intramyocitic lipid accumulation and SREBP-1c expression are related to insulin resistance and cardiovascular risk in morbid obesity. Atherosclerosis 2003; 170: 155–161.

    Article  CAS  Google Scholar 

  42. Dobrzyn A, Dobrzyn P, Lee SH, Miyazaki M, Cohen P, Asilmaz E et al. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle. Am J Physiol Endocrinol Metab 2005; 288: E599–E607.

    Article  CAS  Google Scholar 

  43. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ . Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science (New York, NY) 2001; 291: 2613–2616.

    Article  CAS  Google Scholar 

  44. Molero JC, Jensen TE, Withers PC, Couzens M, Herzog H, Thien CB et al. c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action. J Clin Invest 2004; 114: 1326–1333.

    Article  CAS  Google Scholar 

  45. Hulver MW, Berggren JR, Carper MJ, Miyazaki M, Ntambi JM, Hoffman EP et al. Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab 2005; 2: 251–261.

    Article  CAS  Google Scholar 

  46. Pinnamaneni SK, Southgate RJ, Febbraio MA, Watt MJ . Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro. Diabetologia 2006; 49: 3027–3037.

    Article  CAS  Google Scholar 

  47. Tsuchida A, Yamauchi T, Takekawa S, Hada Y, Ito Y, Maki T et al. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes 2005; 54: 3358–3370.

    Article  CAS  Google Scholar 

  48. Kadowaki T, Yamauchi T . Adiponectin and adiponectin receptors. Endocrine Rev 2005; 26: 439–451.

    Article  CAS  Google Scholar 

  49. Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, Olson P et al. Muscle-specific Pparg deletion causes insulin resistance. Nat Med 2003; 9: 1491–1497.

    Article  CAS  Google Scholar 

  50. Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008; 454: 961–967.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank M Pearen, R Fitzsimmons, S Myers, M Wang and all other members of the Muscat Research Group for excellent technical assistance and advice, and to I Ibinabo from the Mater Research Support Centre, Mater Health Services for the growth curve statistical analysis. This study was supported by a National Health and Medical Research Council Project grant #511044 (GML, GEOM, ECH, AJK); an USA Endocrine Society Bridge Grant; a Golden Casket Mater Children's Hospital Grant and an ANZ Bank Child Health Establishment Award to GML. GML is a NHMRC Clinical Career Development Awardee (CDA) and was a Queensland Smart State Clinical Research Fellow during the project; NT is a NHMRC Biomedical CDA; GEOM and GJC are NHMRC Research Fellows.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to G M Leong or G E O Muscat.

Additional information

Supplementary Information accompanies the paper on International Journal of Obesity website (http://www.nature.com/ijo)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leong, G., Kee, A., Millard, S. et al. The Ski proto-oncogene regulates body composition and suppresses lipogenesis. Int J Obes 34, 524–536 (2010). https://doi.org/10.1038/ijo.2009.265

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2009.265

Keywords

This article is cited by

Search

Quick links